Symphony Limited (SYMPHONY) Financial Results — Revenue ₹338 Cr

Revenue: ₹338 CrNet Profit: ₹-141 Cr

📢 Key Event
Symphony Limited reported Q4 FY26 consolidated revenue of ₹338 crores, down from ₹488 crores, with PAT at negative ₹141 crores after impairments.

🔄 What Changed
Consolidated revenue declined 30.7% YoY to ₹338 crores; PAT turned negative ₹141 crores due to impairments; Australia business impairments totaled ₹259 crores; ₹165 crores loan repaid; U.S. and Mexico subsidiaries acquired for ₹52 crores total.

🔮 What's Next
No further capital investment in Australia business; U.S. and GSK China to become capital accretive; GSK China loan repayment of ₹4 crores expected in next 6 months; distribution model shift for Australia to reduce fixed costs; BISP products to achieve EBITDA margins in line with air cooler business.

💡 Investor Takeaway
Symphony is restructuring its international operations to improve capital efficiency, focusing on profitable segments while exiting loss-making ventures, maintaining shareholder returns despite impairments.

Symphony Limited reported consolidated revenue of ₹338 crores for Q4 FY26, down from ₹488 crores in the previous quarter, with gross margin stable at 46.4%. The company recorded a consolidated PAT of negative [amount context mismatch] crores after impairments, while stand-alone revenue declined to ₹199 crores from ₹368 crores. Management highlighted successful restructuring of Australia operations, repayment of ₹165 crores in loans, and acquisition of U.S. business assets for ₹52 crores. Despite challenges in Australia, the company emphasized capital efficiency, no further investments in the region, and maintained dividend payout of ₹62 crores. Gross margins remained resilient at 46.4% despite cost pressures, with expectations of passing on PVC price increases. The business demonstrated strength in Beyond India Summer Products, contributing ₹192 crores in revenue, and showed early signs of recovery in key Indian markets during April.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SYMPHONY ✨ Ask AI About This